GIARDIA LAMBLIA - ANVISA Registration 10259610091
Access comprehensive regulatory information for GIARDIA LAMBLIA in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10259610091 and manufactured by SCIMEDX CORPORATION. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, EPITOPE DIAGNOSTICS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10259610091
25351560915200916
68814961000173
Company Information
Dates and Status
Dec 28, 2009
VIGENTE
09/18/2025 19:00:01
GIARDIA LAMBLIA
RIDASCREEN® Giardia
R-BIOPHARM AG
82890930004
Feb 17, 2025
GIARDIA LAMBLIA
Giardia lamblia - TF Quicktest
BIO BRASIL CIENCIA E TECNOLOGIA LTDA
81249610021
Jan 15, 2024
GIARDIA LAMBLIA
CORIS Bioconcept® Giardia-Strip
Nanosens Ltda
81546350058
Jan 15, 2024
GIARDIA LAMBLIA
Cassete de Teste Rápido de Giardia lamblia (Fezes)
HANGZHOU ALLTEST BIOTECH CO. LTD
81325990253
Jun 05, 2023
GIARDIA LAMBLIA
FASTLINE GIARDIA LAMBLIA Ag
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA
80105220129
Apr 17, 2023

